DK0465744T3 - Formuleringer for sårforbindinger med vedvarende afgivelse og deres anvendelse - Google Patents

Formuleringer for sårforbindinger med vedvarende afgivelse og deres anvendelse

Info

Publication number
DK0465744T3
DK0465744T3 DK90311291.0T DK90311291T DK0465744T3 DK 0465744 T3 DK0465744 T3 DK 0465744T3 DK 90311291 T DK90311291 T DK 90311291T DK 0465744 T3 DK0465744 T3 DK 0465744T3
Authority
DK
Denmark
Prior art keywords
wound dressing
dressing formulations
sustained wound
sustained
formulations
Prior art date
Application number
DK90311291.0T
Other languages
English (en)
Inventor
Alain Etienne
Louis Michel Jacques Aguadish
Original Assignee
Dow Corning Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Corning Sa filed Critical Dow Corning Sa
Application granted granted Critical
Publication of DK0465744T3 publication Critical patent/DK0465744T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK90311291.0T 1989-10-23 1990-10-16 Formuleringer for sårforbindinger med vedvarende afgivelse og deres anvendelse DK0465744T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR898913819A FR2653338B1 (fr) 1989-10-23 1989-10-23 Formulation pour des pansements a liberation prolongee de medicament et son utilisation.

Publications (1)

Publication Number Publication Date
DK0465744T3 true DK0465744T3 (da) 1995-01-23

Family

ID=9386647

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90311291.0T DK0465744T3 (da) 1989-10-23 1990-10-16 Formuleringer for sårforbindinger med vedvarende afgivelse og deres anvendelse

Country Status (13)

Country Link
US (1) US5480653A (da)
EP (1) EP0465744B1 (da)
JP (1) JP2997714B2 (da)
KR (1) KR910007508A (da)
AU (1) AU635974B2 (da)
BR (1) BR9005261A (da)
CA (1) CA2027864C (da)
DE (1) DE69014614T2 (da)
DK (1) DK0465744T3 (da)
FI (1) FI905196A7 (da)
FR (1) FR2653338B1 (da)
HU (1) HUT61492A (da)
IE (1) IE65720B1 (da)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2752380B1 (fr) * 1996-08-14 1998-10-30 Dow Corning Sa Procede de fabrication d'un dispositif a liberation controlee
FR2760971B1 (fr) * 1997-03-20 1999-12-10 Dow Corning Sa Procede de production d'une composition a liberation controlee
US6512072B1 (en) 2000-06-12 2003-01-28 Dow Corning Corporation Fast cure film forming formulation
WO2002007674A2 (en) * 2000-07-21 2002-01-31 Ceramoptec Industries, Inc. Enhancing compound penetration into hair follicles
US6855135B2 (en) 2000-11-29 2005-02-15 Hill-Rom Services, Inc. Vacuum therapy and cleansing dressing for wounds
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
US20040234572A1 (en) * 2001-09-11 2004-11-25 Martinod Serge R. Preparation of sustained release pharmaceutical composition
GB2407496A (en) * 2003-10-27 2005-05-04 Dow Corning Method for forming a polysiloxane film on a biological surface
WO2005053641A1 (en) * 2003-12-05 2005-06-16 Namibia Medical Investments (Pty) Limited Patch
EP1811933B1 (en) 2004-09-28 2016-03-23 Atrium Medical Corporation Barrier layer
US8312836B2 (en) * 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9000040B2 (en) * 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2006036982A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Drug delivery coating for use with a stent
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
US9801982B2 (en) * 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US20090011116A1 (en) * 2004-09-28 2009-01-08 Atrium Medical Corporation Reducing template with coating receptacle containing a medical device to be coated
EP1833918B1 (en) 2004-12-23 2011-09-28 Dow Corning Corporation Crosslinkable saccharide-siloxane compositions, and networks, coatings and articles formed therefrom
WO2006127883A2 (en) 2005-05-23 2006-11-30 Dow Corning Corporation Personal care compositions comprising saccharide-siloxane copolymers
US9278161B2 (en) * 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
WO2007047781A2 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
US8034323B2 (en) 2005-12-21 2011-10-11 Avon Products, Inc. Cosmetic compositions having in-situ silicone condensation cross-linking
US7750106B2 (en) 2005-12-21 2010-07-06 Avon Products, Inc. Cosmetic compositions having in-situ hydrosilylation cross-linking
EP2019678A4 (en) 2006-05-23 2012-05-02 Dow Corning NOVEL SILICON FILM FORMERS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
EP2083875B1 (en) 2006-11-06 2013-03-27 Atrium Medical Corporation Coated surgical mesh
US9492596B2 (en) * 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
FR2910297A1 (fr) * 2006-12-20 2008-06-27 Oreal Composition comprenant un compose x et un compose y dont l'un au moins est silcone, et un colorant direct hydrophile
FR2910312A1 (fr) 2006-12-20 2008-06-27 Oreal Procede de traitement des cheveux par une silicone reactive vinylique capable de reagir par hydrosilylation
WO2008075301A2 (en) * 2006-12-20 2008-06-26 L'oreal Cosmetic product comprising silicone compounds and reflective particles with metallic reflection
FR2910315B1 (fr) * 2006-12-20 2010-04-02 Oreal Composition cosmetique a film hydrophobe
FR2910286B1 (fr) 2006-12-20 2009-04-17 Oreal Composition comprenant des composes silicones encapsules
FR2910313A1 (fr) 2006-12-20 2008-06-27 Oreal Obtention de coiffures structurees mettant en oeuvre une composition comprenant des composes silicones reactifs
FR2910301B1 (fr) 2006-12-20 2009-04-03 Oreal Procede de traitement des fibres capillaires avec des compositions contenant des silicones reactives
FR2910303A1 (fr) 2006-12-20 2008-06-27 Oreal Composition comprenant un compose x et un compose y dont l'un au moins est silicone et un colorant direct hydrophobe
FR2910287B1 (fr) * 2006-12-20 2009-04-17 Oreal Produit cosmetique comprenant des composes silicones et un polymere hydratant
FR2910306A1 (fr) * 2006-12-20 2008-06-27 Oreal Produit cosmetique comprenant des composes silicones et des particules reflechissantes a reflexion metalique
FR2910305B1 (fr) * 2006-12-20 2010-03-12 Oreal Kit de revetement des cils comprenant des composes x et y silicones et des fibres
FR2910298A1 (fr) 2006-12-20 2008-06-27 Oreal Composition tinctoriale contenant une silicone reactive, un colorant fluorescent ou azurant optique, procede de coloration utilisant la composition
FR2910299A1 (fr) 2006-12-20 2008-06-27 Oreal Traitement de fibres capillaires a partir d'une composition comprenant des pigments et des composes silicones reactifs
FR2910311B1 (fr) 2006-12-20 2009-02-13 Oreal Composition comprenant un compose silicone et un organosilane particulier
FR2910345A1 (fr) 2006-12-20 2008-06-27 Oreal Particules coeur/ecorce a base de composes silicones
WO2008075282A2 (en) * 2006-12-20 2008-06-26 L'oreal Cosmetic kit for providing a hydrophobic film
FR2910314B1 (fr) 2006-12-20 2009-05-08 Oreal Traitement de fibres capillaires a partir d'une composition comprenant des composes silicones reactifs avant ou apres un procede de coloration
WO2008074870A2 (en) * 2006-12-20 2008-06-26 L'oreal Lash coating kit comprising silicone compounds x and y and fibres
US20080188446A1 (en) * 2007-02-02 2008-08-07 Warner Chilcott Company Inc. Tetracycline compositions for topical administration
WO2008097850A1 (en) * 2007-02-02 2008-08-14 Warner Chilcott Company, Inc. Tretracycline compositions for topical administration
US8852558B2 (en) * 2008-03-11 2014-10-07 Materials Modification, Inc. In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide and platinum catalyst
KR100859339B1 (ko) * 2008-04-23 2008-09-22 주식회사 원바이오젠 드레싱재용 실리콘 조성물 및 이를 이용한 드레싱재와 그제조방법
FR2933614B1 (fr) 2008-07-10 2010-09-10 Oreal Kit de protection solaire.
CN102449073B (zh) 2009-07-03 2013-11-13 道康宁公司 成膜的含硅酮组合物
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
EP2593141B1 (en) 2010-07-16 2018-07-04 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
WO2012018068A1 (ja) 2010-08-06 2012-02-09 大日本住友製薬株式会社 水溶性薬物放出制御製剤
CN103140226B (zh) * 2010-08-06 2015-07-08 大日本住友制药株式会社 用于治疗脊髓损伤的制剂
WO2012027073A1 (en) 2010-08-23 2012-03-01 Dow Corning Corporation Saccharide siloxanes stable in aqueous environments and methods for the preparation and use of such saccharide siloxanes
CN103347496A (zh) 2010-12-27 2013-10-09 道康宁公司 药物递送分散体以及由其形成的膜
FR2973236B1 (fr) 2011-03-31 2013-12-13 Oreal Utilisation d'un dispositif de transfert d'un film cosmetique anti-transpirant applique sur la peau
FR2973244B1 (fr) 2011-03-31 2014-01-24 Oreal Procede comprenant l'application d'un materiau anti-transpirant contenant au moins deux zones de polymeres differents
EP2741788A4 (en) * 2011-08-14 2015-03-25 Materials Modification Inc METHOD AND COMPOSITION FOR IN-SITU FORMATION OF AN ARTIFICIAL BARRIER FOR FIGHTING BLOOD LOSS
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
WO2019045830A1 (en) 2017-08-31 2019-03-07 Dow Silicones Corporation COSMETIC COMPOSITIONS
FR3084590B1 (fr) 2018-07-31 2021-01-08 Lvmh Rech Produit cosmetique en emulsion comprenant des silicones fonctionnalisees
FR3084589B1 (fr) 2018-07-31 2021-01-08 Lvmh Rech Produit cosmetique comprenant des silicones fonctionnalises et un polymere tenseur
FR3084591B1 (fr) 2018-07-31 2021-01-08 Lvmh Rech Produit cosmetique comprenant des silicones fonctionnalisees
JP2020111528A (ja) * 2019-01-10 2020-07-27 株式会社佐野商会 生体被覆膜材料、生体被覆膜及び生体被覆膜の形成方法
CN117835966A (zh) * 2021-09-09 2024-04-05 株式会社资生堂 水溶性药剂的皮肤渗透促进方法
JPWO2023037984A1 (da) * 2021-09-09 2023-03-16

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1357737A (en) * 1970-10-09 1974-06-26 Arpic Sa Sustained release pharmaceutical compositions
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
US4053580A (en) * 1975-01-01 1977-10-11 G. D. Searle & Co. Microsealed pharmaceutical delivery device
US4189546A (en) * 1977-07-25 1980-02-19 Bausch & Lomb Incorporated Polysiloxane shaped article for use in biomedical applications
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
GB8704755D0 (en) * 1987-02-28 1987-04-01 Dow Corning Ltd Pharmaceutical delivery device

Also Published As

Publication number Publication date
FI905196A0 (fi) 1990-10-22
AU635974B2 (en) 1993-04-08
FR2653338B1 (fr) 1994-06-10
BR9005261A (pt) 1991-09-17
JP2997714B2 (ja) 2000-01-11
DE69014614D1 (de) 1995-01-12
AU6486490A (en) 1991-04-26
FR2653338A1 (fr) 1991-04-26
CA2027864C (en) 1999-10-12
JPH03151322A (ja) 1991-06-27
IE903776A1 (en) 1991-04-24
CA2027864A1 (en) 1991-04-24
KR910007508A (ko) 1991-05-30
FI905196A7 (fi) 1991-04-24
EP0465744B1 (en) 1994-11-30
HU906526D0 (en) 1991-04-29
IE65720B1 (en) 1995-11-15
US5480653A (en) 1996-01-02
EP0465744A1 (en) 1992-01-15
HUT61492A (en) 1993-01-28
DE69014614T2 (de) 1995-05-04

Similar Documents

Publication Publication Date Title
DK0465744T3 (da) Formuleringer for sårforbindinger med vedvarende afgivelse og deres anvendelse
NO941929L (no) Tokotrienoler og tokotrienol-lignende sammensetninger og fremgangsmåter for deres anvendelse
DK543189A (da) Lysyloxidaseinhibitorer og deres anvendelse
FI941537A7 (fi) Uudet tehokkaat, terminaalisen erilaistumisen indusoivat aineet sekä menetelmät niiden käyttämiseksi
NO954239D0 (no) Heterocykliske forbindelser og deres fremstilling og anvendelse
DK349088D0 (da) Haerdelige blandinger og deres anvendelse
FI934189A7 (fi) Transdermalt terapeutiskt plaoster
DK35591D0 (da) Saarforbinding
DK183488D0 (da) Furanderivater og anvendelse deraf
NO942301D0 (no) Imidazokinazolinforbindelser og deres fremstilling og anvendelse
DK4491D0 (da) Aclonifen-baserede herbicidblandinger og deres anvendelse
NO914288D0 (no) Nye 2-sakkarinylmetylarylkarboksylater og fremgangsmaater for deres fremstilling
DK45188D0 (da) Substituerede aminderivater og deres anvendelse
DK293888A (da) Fenolderivater og deres fremstilling og anvendelse
DK246189A (da) Antimikrobielt praeparat og anvendelse deraf
DK0381135T3 (da) Nye hydroxyperoxider og deres anvendelse
NO921834L (no) Smerteregulerende sammensetning og fremgangsmaate for fremstilling
DK360189D0 (da) S-adenosyl-methionin-decarboxylase-inhibitorer, deres fremstilling og anvendelse
DK73091D0 (da) Quinoxalinforbindelser, deres fremstilling og anvendelse
DK225089A (da) 2-adamantyl-4-isothiazolin-3-oner, deres fremstilling og anvendelse
NO922992D0 (no) Imid-terminerte polynitrogenforbindelser, deres fremstilling og anvendelse
DK634089D0 (da) Polyhydroxybenzyloxypropanolaminer og deres anvendelse
KR930008247U (ko) 붕대 절단용 가위
KR910004442U (ko) 고저 조절식 거푸집 지지주
DK455189D0 (da) 2,3,4,5-tetrahydro-1-benzoxepiner, deres fremstilling og anvendelse